Animal Model of Sclerotic Skin. V: Increased Expression of α-Smooth Muscle Actin in Fibroblastic Cells in Bleomycin-Induced Scleroderma

This publication has 31 references indexed in Scilit:

• Anti-sclerotic Effect of Transforming Growth Factor-β Antibody in a Mouse Model of Bleomycin-Induced Scleroderma
  Clinical Immunology, 1999
• Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking Scleroderma
  Journal of Investigative Dermatology, 1999
• Modulation of α‐smooth muscle actin expression in fibroblasts by transforming growth factor‐β isoforms: an in vivo and in vitro study
  Wound Repair and Regeneration, 1996
• Myofibroblasts from Scleroderma Skin Synthesize Elevated Levels of Collagen and Tissue Inhibitor of Metalloproteinase (TIMP-1) with Two Forms of TIMP-1
  Journal of Biological Chemistry, 1995
• Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
  The Journal of cell biology, 1993
• Locally applied GM-CSF induces the accumulation of α-smooth muscle act in containing myofibroblasts
  Virchows Archiv B Cell Pathology Including Molecular Pathology, 1991
• Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.
  Journal of Clinical Investigation, 1990
• Transcription and Expression of Transforming Growth Factor Type Beta in the Skin of Progressive Systemic Sclerosis: A Mediator of Fibrosis?
  Journal of Investigative Dermatology, 1990
• Systemic scleroderma: Clinical and pathophysiologic aspects
  Journal of the American Academy of Dermatology, 1988
• Collagen Biosynthesis in Systemic Scleroderma: Regulation of Posttranslational Modifications and Synthesis of Procollagen in Cultured Fibroblasts
  Journal of Investigative Dermatology, 1985